Price$479.36+12.58 (+2.70%)
01:30 PM07:45 PM
News · 26 weeks89-25%
2025-11-022026-04-26
Mix5090d
- Insider28(56%)
- SEC Filings11(22%)
- Other7(14%)
- Earnings2(4%)
- Dividends1(2%)
- Analyst1(2%)
Latest news
25 items- INSIDERPresident & COO Pettiti Gianluca sold $185,064 worth of shares (400 units at $462.66) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 25,051 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- PRThermo Fisher Scientific to Host Investor DayThermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, will hold its 2026 Investor Day on Wednesday, May 20, 2026, starting at 9:00 a.m. ET in New York City. The format will feature presentations by members of Thermo Fisher Scientific's senior management team and conclude with a Q&A session. The live webcast of the presentation can be accessed via the Investors section of our website, https://ir.thermofisher.com. A replay of the webcast will be available following the presentation. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to
- PRThermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to AstorgThermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing. The business generated $645 million in revenue in 2025 and is part of Thermo Fisher's Specialty Diagnostics segment. "The transaction reflects our active management of the company and provides additional capital we
- SECThermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- PRThermo Fisher Scientific Reports First Quarter 2026 ResultsThermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 28, 2026. First Quarter Highlights First quarter revenue grew 6% to $11.01 billion. First quarter GAAP diluted earnings per share (EPS) grew 11% to $4.43. First quarter adjusted EPS grew 6% to $5.44. Delivered excellent performance in the first quarter, demonstrating the strength of our proven growth strategy, the power of our PPI Business System, and the continued active management of our company. Advanced our proven growth strategy, launching a range of high-impact, innovative new products during the quarter. This includ
- PRAI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost AdvantagesAUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: As regulatory demands intensify and production environments become more complex, pharmaceutical manufacturers are shifting beyond traditional quality assurance systems toward a new operational model: integrating artificial intelligence directly into manufacturing workflows as a continuous compliance layer. Rather than depending on retrospective audits and manual checks, AI-driven technologies are now capable of monitoring, validating and optimizing production processes in real time to ensure alignment with evolving Good Manufacturing Practice (GMP) requirements. This transformation is becoming increasingly vis
- PRThermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale ProteomicsThermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the PRECISE-SG100K study, one of the region's most ambitious and diverse population-scale biobank initiatives. The collaboration reflects growing investments from national population studies looking to harness proteomics to drive insight into real-time disease biology for application in earlier detection, prevention and personalized care. As biobanks become central to national health strategies over the next decade, the integration of multi-omic platforms and AI-driven analytics is critical. When applied to
- SECSEC Form DEFA14A filed by Thermo Fisher Scientific IncDEFA14A - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- SECSEC Form DEF 14A filed by Thermo Fisher Scientific IncDEF 14A - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- PRThermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2026 before the market opens on Thursday, April 23, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the "Investors" section of our website, www.thermofisher.com. You can access the conference call by dialing (833) 470-1428 within the U.S. or +1 (646) 844-6383 outside the U.S. The access code is 723173. The earnings press release and related information can also be found in that sec
- INSIDERSEC Form 4 filed by Sperling Scott M4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSEC Form 4 filed by Keith R. Alexandra4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSEC Form 4 filed by Lynch Karen S4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSEC Form 4 filed by Johnson Jennifer M4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSEC Form 4 filed by Weisler Dion J4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- ANALYSTDZ Bank initiated coverage on Thermo Fisher with a new price targetDZ Bank initiated coverage of Thermo Fisher with a rating of Buy and set a new price target of $610.00
- SECThermo Fisher Scientific Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- PRThermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc.Further strengthens Thermo Fisher's position as the trusted partner to pharma and biotech customers, delivering important customer benefits Attractive return profile given high growth and strong margin profile of Clario, and meaningful synergies – reflecting the company's disciplined approach to capital deployment Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the completion of its acquisition of Clario Holdings, Inc., a leading provider of endpoint data solutions for clinical trials, for $8.875 billion in cash, plus potential additional earnout and other payments, largely dependent on performance. With the transaction complete, the Clario
- INSIDERExecutive Vice President Shafer Michael D sold $802,536 worth of shares (1,607 units at $499.40), decreasing direct ownership by 7% to 20,950 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERNew insider Meyer James claimed ownership of 5,891 shares (SEC Form 3)3 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERChairman & CEO Casper Marc N exercised 4,000 shares at a strike of $309.63 and sold $2,059,261 worth of shares (4,000 units at $514.82) (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERChairman & CEO Casper Marc N sold $5,077,489 worth of shares (10,000 units at $507.75) and exercised 10,000 shares at a strike of $309.63 (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- SECSEC Form 144 filed by Thermo Fisher Scientific Inc144 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Subject)
- SECSEC Form 144 filed by Thermo Fisher Scientific Inc144 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Subject)
- INSIDERChairman & CEO Casper Marc N covered exercise/tax liability with 4,685 shares, decreasing direct ownership by 4% to 123,925 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
TMO FAQ
7 questionsWhat does Thermo Fisher Scientific Inc do?
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in...Where does TMO stock trade?
Thermo Fisher Scientific Inc (TMO) is listed on NYSE.What sector and industry is TMO in?
Thermo Fisher Scientific Inc operates in the Industrials sector, Industrial Machinery/Components industry.Does TMO pay a dividend?
TMO's most recent ex-dividend date was 2026-03-13 with a cash dividend of $0.47 per share. No future ex-date is on file yet.What are analysts saying about TMO?
Thermo Fisher Scientific Inc has had 8 recent analyst actions on file. The most recent action was from DZ Bank: Buy on 2026-03-27.What companies are similar to TMO?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), ETN (Eaton Corporation PLC), DE (Deere & Company), DHR (Danaher Corporation). Compare TMO side-by-side with any of them on Quantisnow.How can I track TMO on Quantisnow?
Quantisnow aggregates Thermo Fisher Scientific Inc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TMO to receive live email and push alerts on every new disclosure.